Risk grade updatedRisk gradeEvidence verified
26 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.Business profile
ApoMed Oy
ApoMed Oy's registered office is Vaasa. It is a limited company. The company was established on 2005-03-24. It operates in the industry of retail sale of other medical and orthopaedic goods. In its latest retained statement for 2025-12-31, revenue was €0 and operating profit was €29,143.
Business ID 1955028-0ValidUnclaimed company profile
Trusted core data
Public company details from the trade register.
- Business ID
- 1955028-0
- Sector
- Retail sale of other medical and orthopaedic goods
- Municipality
- Vaasa
- Company form
- Limited company
- Registration date
- 2005-03-24
- Business ID registration date
- 2005-03-18
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: Saaristokatu 1 A, 65170, Vaasa
Phone: +35863196450Source observation
Email: [email protected]Source observation
Website: https://www.internetapteekki.fiSource observation
People and decision-makers
Nuutila Ditte MaiToimitusjohtaja
About ApoMed Oy
Financial position and key figures for the company.
ApoMed Oy's location municipality is Vaasa. It is a limited company. The company was established on 2005-03-24. It operates in the industry of retail sale of other medical and orthopaedic goods. In its latest retained statement for 2025-12-31, revenue was €0 and operating profit was €29,143. The latest retained financial statement for 2025-12-31 shows revenue of €0 and profit for the financial year of €80,851. Based on the latest retained statement, revenue growth was not currently available, operating margin was not currently available, and equity ratio was +99.7%.
Auxiliary business names
Public alternate names materialized from source observations.
ApoMed AbApoMed Ltd
Extended business activity
A longer directory- or registry-backed activity description that complements the short registry industry label.
Yhtiön toimialana on lääketieteellisten ja terveydenhoitoon liittyvien tuotteiden ja tarvikkeiden, luontaistuotteiden, kosmetiikan ja elintarvikkeiden vähittäis- ja tukkumyynti, tuonti, vienti ja valmistus, työvoiman sekä koneiden, laitteiden, kalusteiden, asuin- ja liikekiinteistöjen sekä huoneistojen vuokraus, osto ja myynti. Yhtiö voi myös omistaa ja hallita arvopapereita, kiinteää ja irtainta omaisuutta, ostaa ja myydä arvopapereita, ostaa ja myydä asunto- ja kiinteistöyhtiön osakkeita sekä asuin- ja liikekiinteistöjä. Yhtiön toimialaan kuuluu myös lääke- ja apteekkialaan liittyvä liikkeenjohdon ja muu konsultointi, tuotekehitys sekä markkinointi- ja lääkäripalvelujen myynti.
Financial highlights
Key figures from the latest financial period.
Latest financial period
2025-12-31
0
0
Enriched source observation
Derived indicators
Equity ratio99.7%
Revenue€0+€0 vs previous periodPrevious: €0
Operating profit (loss)€29,143+€28,557 (+4871.8%) vs previous periodPrevious: €586
Profit (loss) for the financial year€80,851-€30,159 (-27.2%) vs previous periodPrevious: €111,010
Assets€4,999,151-€342,068 (-6.4%) vs previous periodPrevious: €5,341,219
Balance-sheet contextLatest financial period
Employees0Previous: 0
Revenue trend5 periods
€2,213,752
2021-12-31
€2,266,839
2022-12-31
€1,532,739
2023-12-31
€0
2024-12-31
€0
2025-12-31
Operating profit (loss) trend5 periods
€824,809
2021-12-31
€821,796
2022-12-31
€521,580
2023-12-31
€586
2024-12-31
€29,143
2025-12-31
Profit (loss) for the financial year trend5 periods
€928,992
2021-12-31
€701,482
2022-12-31
€501,484
2023-12-31
€111,010
2024-12-31
€80,851
2025-12-31
Assets trend5 periods
€5,464,176
2021-12-31
€5,810,427
2022-12-31
€5,687,077
2023-12-31
€5,341,219
2024-12-31
€4,999,151
2025-12-31
Financial ratios
Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.
Equity ratioGood
100/100 · Declining
Current ratioNot assessable
0/100 · Trend unavailable
Operating profit marginNot assessable
0/100 · Trend unavailable
Ratio history
| Ratio | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|
| Equity ratio | 98.2 % | 97.0 % | 99.9 % | 99.9 % | 99.7 % |
| Current ratio | - | - | - | - | - |
| Operating profit margin | 35.8 % | 35.0 % | 32.1 % | - | - |
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
YTJ statusValid
Trade RegisterRegistered
Business ID1955028-0
VAT IDFI19550280
EU IDFIFPRO.1955028-0
MunicipalityVaasa
Current registered entries
2005-03-01VAT-liable for business activity in Tax Administration (VAT Register)
2005-03-18Registered in Tax Administration (Prepayment Register)
2005-03-24Registered in Patent and Registration Office (Trade Register)
2005-03-29Registered in Tax Administration (Tax Administration)
2007-05-24VAT-obliged for the transfer of rights to use immovable property in Tax Administration (VAT Register)
Responsible people
Public role relationships materialized from source observations.
Nuutila Ditte MaiToimitusjohtajaSources: 6 · Confidence: 78%
Nuutila Juha PaavoPuheenjohtajaSources: 6 · Confidence: 78%
Täckström Nina Johanna DanielaVarsinainen jäsenSources: 5 · Confidence: 78%
Jåfs Hans Jan AndersTilintarkastajaSources: 2 · Confidence: 78%
Nuutila Ditte MaiVarsinainen jäsenSources: 3 · Confidence: 78%
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
Automatic gradeNot a credit decision
B1
StableApoMed Oy
Grade downgradedA3 → B1 · new analysis 2026-10-17
65/100
Medium
Limited financial evidenceRegistry and statistics based
Financial development is mostly stable or mixed.
4 comparable periodsProfitabilityNot enough history
SolvencyStable
LiquidityNot enough history
Supporting factors
- Company context reduces the weight of an isolated financial signal
- Active registered status
- A newer financial statement filing has been reported
Risk factors to note
- Elevated industry distress context
- Sufficient structured financial metrics are not available
Automatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
2 assessmentsB1
2026-10-1765/100 · v0.15
A3 → B1 · -6 points- Assessment confidence: Low → Medium.
- Evidence quality: Usable financial evidence → Limited financial evidence.
- New risk factor: Sufficient structured financial metrics are not available.
A3
2026-09-2671/100 · v0.14
Oldest retained automatic assessment in this comparisonB1
2026-10-17
open-risk-grade-v0.15
The grade uses registry, industry, and regional signals because sufficient source-backed financial metrics are not available for a Tier 1 assessment.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry riskelevated
46/100
Industry context is elevated based on normalized open statistical inputs.
Age and continuityVakiintunut
80/100
The company has about 21 years of registry continuity.
Registry and status signalsVakaa
78/100
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Registry timeline
Trade register notifications shown on a timeline.
15 register eventsLatest event: 2026-04-30
Profile source and ownership
Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.
This company profile has not been claimed yet
ApoMed Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.